Cilostazol (Compound)

Synonyms:cilostazol, 73963-72-1, Pletal, Cilostazole, Pletaal, OPC-13013, Cilostazolum, Cilostazolum [INN-Latin], OPC 13013, OPC 21, OPC-21, 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one, C20H27N5O2, 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone, 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one, UNII-N7Z035406B, CHEBI:31401, 3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone, 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril, 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one, 6-[4-(1-cyclohexyl-1H-1,2,3,4-tetrazol-5-yl)butoxy]-1,2,3,4-tetrahydroquinolin-2-one, MLS000028470, 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone, MFCD00866780, N7Z035406B, NCGC00015207-07, SMR000058428, DSSTox_CID_25132, DSSTox_RID_80693, DSSTox_GSID_45132, CAS-73963-72-1, Pletal (TN), SR-01000003107, BRN 3632107, Cilostazol,(S), Cilostazol-[d11], Cilostazol [USAN:USP:INN:BAN:JAN], Tocris-1692, Opera_ID_488, Spectrum2_001118, Spectrum3_001170, Spectrum4_000772, Spectrum5_001762, Lopac-C-0737, CHEMBL799, C 0737, Lopac0_000218, REGID_for_CID_2754, SCHEMBL16128, BSPBio_002759, KBioGR_001184, MLS000758281, MLS000759507, MLS001076067, MLS002153891, SPECTRUM1505230, SPBio_001256, Cilostazol (JP17/USP/INN), GTPL7148, DTXSID9045132, HSDB 8312, KBio3_002259, BCPP000279, HMS1922N15, HMS2093M14, HMS2096F16, HMS2234C06, HMS3260L17, HMS3268O09, HMS3412B18, HMS3654J13, HMS3676B18, HMS3713F16, Pharmakon1600-01505230, ACT02663, BCP03724, ZINC1552174, Tox21_110098, Tox21_500218, BDBM50225508, CCG-39646, NSC758936, s1294, AKOS015855512, Cilostazol, >=98% (HPLC), powder, OPC 13013; OPC 21; Pletaal, Tox21_110098_1, AC-4334, AM90304, BCP9000530, CS-1759, DB01166, KS-5154, LP00218, MCULE-8893820969, NSC 758936, NSC-758936, SDCCGSBI-0050206.P003, 2(1H)-Quinolinone, 3,4-dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-, 2(1H)-Quionlinone, 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-

Pubchem:PUBCHEM:2754

Id:2754

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Cilostazol's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Cilostazol.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Cilostazol.

Results found

Linked to

	Label	Description
	BRD-K67017579-001-26-5 Substance (Entity type)	A Substance
	cilostazol (56913f46-d713-426c-93bf-31fb061e8e31) Collection (Entity type)	Metadatata for cilostazol
	DCSTRUCT ID 00644 Collection (Entity type)	DrugPage Collection: (DrugCentralID:00644; PubChem_CID:2754, FILE=drugcentral_drug_00644.json)
	cilostazol positively regulates CXCL1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	cilostazol negatively regulates DPP4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	cilostazol positively regulates SERPINF1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	cilostazol positively regulates KRT5 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	cilostazol positively regulates SERPINA3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	cilostazol negatively regulates ARG2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	cilostazol positively regulates STEAP1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS